The Inflation Reduction Act's broken promise is still costing patients

Global Business Fri, 18 Sep 2026 16:50:58 GMT Moderate confidence — 71/100

Critics argue that the Inflation Reduction Act is increasing costs and reducing patient access to medications through price negotiations and Medicare Part D restructuring.

Unverified

Critics argue that the Inflation Reduction Act is increasing costs and reducing patient access to medications through price negotiations and Medicare Part D restructuring.

Sources: The Hill